|
1
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3
|
Peppone LJ, Mahoney MC, Cummings KM,
Michalek AM, Reid ME, Moysich KB and Hyland A: Colorectal cancer
earlier in those exposed to tobacco smoke: implication for
screening. J Cancer Res Clin Oncol. 134:743–751. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamburger AW and Salmon SE: Primary
bioassay of human tumor stem cells. Science. 197:461–463. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boman BM and Wicha MS: Cancer stem cells:
a step toward the cure. J Clin Oncol. 26:2795–2799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdul Khalek FJ, Gallicano GI and Mishra
L: Colon cancer stem cells. Gastrointest Cancer Res. Nov;(Suppl 1):
S16–S23. 2010.
|
|
7
|
Sophos NA and Vasiliou V: Aldehyde
dehydrogenase gene superfamily: the 2002 update. Chem Biol
Interact. 143–144:5–22. 2003.PubMed/NCBI
|
|
8
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, et al: Aldehyde dehydrogenase 1 is a marker
for normal and malignant human colonic stem cells (SC) and tracks
SC overpopulation during colon tumorigenesis. Cancer Res.
69:3382–3389. 2009. View Article : Google Scholar
|
|
9
|
Patel M, Lu L, Zander DS, Sreerama L, Coco
D and Moreb JS: ALDH1A1 and ALDH3A1 expression in lung cancers:
correlation with histologic type and potential precursors. Lung
Cancer. 59:340–349. 2008. View Article : Google Scholar
|
|
10
|
Nogami T, Shien T, Tanaka T, Nishiyama K,
Mizoo T, Iwamto T, et al: Expression of ALDH1 in axillary lymph
node metastases is a prognostic factor of poor clinical outcome in
breast cancer patients with 1–3 lymph node metastases. Breast
Cancer. Mar 10–2012.(Epub ahead of print).
|
|
11
|
Corbeil D, Roper K, Hellwig A, Tavian M,
Miraglia S, Watt SM, et al: The human AC133 hematopoietic stem cell
antigen is also expressed in epithelial cells and targeted to
plasma membrane protrusions. J Biol Chem. 275:5512–5520. 2000.
View Article : Google Scholar
|
|
12
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, et al: Identification of human brain tumor
initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin S, Li J, Hu C, Chen X, Yao M, Yan M,
et al: CD133 positive hepatocellular carcinoma cells possess high
capacity for tumorigenicity. Int J Cancer. 120:1444–1450. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hermann PC, Huber SI, Herrler T, Aicher A,
Ellwart JW, Guba M, et al: Distinct populations of cancer stem
cells determine tumor growth and metastatic activity in human
pancreatic cancer. Cell Stem Cell. 1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, et al: Identification and expansion of
the tumorigenic lung cancer stem cell population. Cell Death
Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumor
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
18
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Todaro M, Alea MP, Di Stefano AB,
Cammareri P, Vermeulen L, Lovino F, et al: Colon cancer stem cells
dictate tumor growth and resist cell death by production of
interleukin-4. Cell Stem Cell. 1:389–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ieta K, Tanaka F, Haraguchi N, Kita Y,
Sakashita H, Mimori K, et al: Biological and genetic
characteristics of tumor-initiating cells in colon cancer. Ann Surg
Oncol. 15:638–648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Br J Cancer. 99:1285–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich
SM, Fields JZ and Boman BM: Evidence that APC regulates surviving
expression: a possible mechanism contributing to the stem cell
origin of colon cancer. Cancer Res. 61:8664–8667. 2001.
|
|
23
|
Boman BM, Walters R, Fields JZ, Kovatich
AJ, Zhang T, Isenberg GA, et al: Colonic crypt changes during
adenoma development in familial adenomatous polyposis:
immunohistochemical evidence for expansion of the crypt base cell
population. Am J Pathol. 165:1489–1498. 2004. View Article : Google Scholar
|
|
24
|
Horst D, Sheel SK, Liebmann S, Neumann J,
Maatz S, Kirchner T and Jung A: The cancer stem cell marker CD133
has high prognostic impact but unknown functional relevance for the
metastasis of human colon cancer. J Pathol. 219:427–434. 2009.
View Article : Google Scholar
|
|
25
|
Shmelkov SV, Butler JM, Hooper AT, Hormigo
A, Kushner J, Milde T, St Clair R, et al: CD133 expression is not
restricted to stem cells and both CD133+ and
CD133− metastatic colon cancer cells initiate tumors. J
Clin Invest. 118:2111–2120. 2008.PubMed/NCBI
|
